Brain Neoplasms

"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Descriptor ID	D001932
MeSH Number(s)	C04.588.614.250.195 C10.228.140.211 C10.551.240.250
Concept/Terms	Brain Neoplasms Brain Neoplasms Neoplasms, Brain Brain Neoplasm Neoplasm, Brain Brain Tumors Brain Tumor Tumor, Brain Tumors, Brain Brain Cancer Brain Cancer Brain Cancers Cancer, Brain Cancers, Brain Malignant Neoplasms, Brain Brain Malignant Neoplasm Brain Malignant Neoplasms Malignant Neoplasm, Brain Cancer of Brain Cancer of the Brain Neoplasms, Brain, Malignant Brain Neoplasms, Malignant Brain Neoplasm, Malignant Malignant Brain Neoplasm Malignant Brain Neoplasms Neoplasms, Intracranial Neoplasms, Intracranial Intracranial Neoplasm Neoplasm, Intracranial Intracranial Neoplasms Brain Tumor, Recurrent Brain Tumor, Recurrent Brain Tumors, Recurrent Recurrent Brain Tumor Recurrent Brain Tumors Malignant Primary Brain Tumors Malignant Primary Brain Tumors Primary Malignant Brain Tumors Malignant Primary Brain Neoplasms Primary Malignant Brain Neoplasms Brain Neoplasms, Malignant, Primary Brain Neoplasms, Primary Malignant Benign Neoplasms, Brain Benign Neoplasms, Brain Benign Neoplasm, Brain Brain Benign Neoplasm Brain Benign Neoplasms Neoplasms, Brain, Benign Brain Neoplasms, Benign Benign Brain Neoplasm Benign Brain Neoplasms Brain Neoplasm, Benign Brain Tumor, Primary Brain Tumor, Primary Brain Tumors, Primary Primary Brain Tumor Primary Brain Tumors Neoplasms, Brain, Primary Brain Neoplasm, Primary Brain Neoplasms, Primary Primary Brain Neoplasm Primary Brain Neoplasms

Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Nervous System Neoplasms [C04.588.614]
Central Nervous System Neoplasms [C04.588.614.250]
Brain Neoplasms [C04.588.614.250.195]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Brain Neoplasms [C10.228.140.211]
Nervous System Neoplasms [C10.551]
Central Nervous System Neoplasms [C10.551.240]
Brain Neoplasms [C10.551.240.250]

Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.

Bar chart showing 79 publications over 24 distinct years, with a maximum of 10 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
1998	0	1	1
2001	1	0	1
2002	1	0	1
2003	1	4	5
2004	1	0	1
2005	3	0	3
2006	1	1	2
2007	6	2	8
2008	3	0	3
2009	0	1	1
2010	1	1	2
2011	4	0	4
2012	5	0	5
2013	3	0	3
2014	4	1	5
2015	5	0	5
2016	3	0	3
2017	9	1	10
2019	4	0	4
2020	4	0	4
2021	2	0	2
2022	2	1	3
2023	2	0	2

Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.

Ortiz-Rivera J, Nu?ez R, Kucheryavykh Y, Kucheryavykh L. The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl/6-Gl261 mouse glioma model. J Neurooncol. 2023 Feb; 161(3):593-604.

View in: PubMed
Chen X, Niu W, Fan X, Yang H, Zhao C, Fan J, Yao X, Fang Z. Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells. Neuro Oncol. 2023 01 05; 25(1):82-96.

View in: PubMed
Seck S, Kim YJG, Cunningham WA, Olshefski R, Yeates KO, Vannatta K, Hoskinson KR. Pilot Study of Associations Among Functional Connectivity and Neurocognition in Survivors of Pediatric Brain Tumor and Healthy Peers. J Child Neurol. 2022 Dec; 37(12-14):927-938.

View in: PubMed
Valdez L, Cheng B, Gonzalez D, Rodriguez R, Campano P, Tsin A, Fang X. Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells. Oncotarget. 2022; 13:642-658.

View in: PubMed
Heinze K, Nazeran TM, Lee S, Kr?mer P, Cairns ES, Chiu DS, Leung SC, Kang EY, Meagher NS, Kennedy CJ, Boros J, Kommoss F, Vollert HW, Heitz F, du Bois A, Harter P, Grube M, Kraemer B, Staebler A, Kommoss FK, Heublein S, Sinn HP, Singh N, Laslavic A, Elishaev E, Olawaiye A, Moysich K, Modugno F, Sharma R, Brand AH, Harnett PR, DeFazio A, Fortner RT, Lubinski J, Lener M, Toloczko-Grabarek A, Cybulski C, Gronwald H, Gronwald J, Coulson P, El-Bahrawy MA, Jones ME, Schoemaker MJ, Swerdlow AJ, Gorringe KL, Campbell I, Cook L, Gayther SA, Carney ME, Shvetsov YB, Hernandez BY, Wilkens LR, Goodman MT, Mateoiu C, Linder A, Sundfeldt K, Kelemen LE, Gentry-Maharaj A, Widschwendter M, Menon U, Bolton KL, Alsop J, Shah M, Jimenez-Linan M, Pharoah PD, Brenton JD, Cushing-Haugen KL, Harris HR, Doherty JA, Gilks B, Ghatage P, Huntsman DG, Nelson GS, Tinker AV, Lee CH, Goode EL, Nelson BH, Ramus SJ, Kommoss S, Talhouk A, K?bel M, Anglesio MS. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. J Pathol. 2022 04; 256(4):388-401.

View in: PubMed
Awah CU, Winter J, Mazdoom CM, Ogunwobi OO. NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction. Cancer Biol Ther. 2021 12 02; 22(10-12):587-597.

View in: PubMed
Reblin M, Ketcher D, McCormick R, Barrios-Monroy V, Sutton SK, Zebrack B, Wells KJ, Sahebjam S, Forsyth P, Byrne MM. A randomized wait-list controlled trial of a social support intervention for caregivers of patients with primary malignant brain tumor. BMC Health Serv Res. 2021 Apr 17; 21(1):360.

View in: PubMed
Cho JH, Lim YC, Han KD, Lee JY, Choi JH. The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey. PLoS One. 2020; 15(11):e0241598.

View in: PubMed
Tran AD, Fogarty G, Nowak AK, Diaby V, Hong A, Watts C, Morton RL. Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases. Appl Health Econ Health Policy. 2020 10; 18(5):679-687.

View in: PubMed
Bhaskaran M, Devegowda VG, Gupta VK, Shivachar A, Bhosale RR, Arunachalam M, Vaishnavi T. Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme. ACS Chem Neurosci. 2020 10 07; 11(19):2962-2977.

View in: PubMed

People

Explore

Similar Concepts

Top Journals